![](images/null.gif) |
![](images/null.gif) |
![](images/null.gif) |
|
Ombitasvir/Paritaprevir/r and Dasabuvir With Ribavirin for HCV Genotype 1 Patients With Decompensated Cirrhosis
|
|
|
Reported by Jules Levin
AASLD 2015 Nov 13-17 San Francisco, CA
Parvez S Mantry1, John Hanson2, Roger Trinh3, Alnoor Ramji4, Linda Fredrick3, Li Liu3, Amit Khatri3, Prajakta Badri3, Leti cia Canizaro3, Manal Abunimeh3, Eric Cohen3, Nancy S Shulman3, Stuart C Gordon5
1The Liver Insti tute at Methodist Dallas, Dallas, Texas, United States; 2Charlott e Gastroenterology & Hepatology, PLLC, Charlott e, North Carolina, United States; 3AbbVie Inc., North Chicago, Illinois, United States; 4University of Briti sh Columbia, Vancouver, Briti sh Columbia, Canada;
5Henry Ford Health System, Detroit, Michigan, United States
![AASLD1.gif](../images/111815/111815-12/AASLD1.gif)
![AASLD2.gif](../images/111815/111815-12/AASLD2.gif)
![AASLD3.gif](../images/111815/111815-12/AASLD3.gif)
![AASLD4.gif](../images/111815/111815-12/AASLD4.gif)
![AASLD5.gif](../images/111815/111815-12/AASLD5.gif)
![AASLD6.gif](../images/111815/111815-12/AASLD6.gif)
![AASLD7.gif](../images/111815/111815-12/AASLD7.gif)
![AASLD8.gif](../images/111815/111815-12/AASLD8.gif)
![AASLD9.gif](../images/111815/111815-12/AASLD9.gif)
![AASLD10.gif](../images/111815/111815-12/AASLD10.gif)
![AASLD11.gif](../images/111815/111815-12/AASLD11.gif)
![AASLD12.gif](../images/111815/111815-12/AASLD12.gif)
![AASLD13.gif](../images/111815/111815-12/AASLD13.gif)
![AASLD14.gif](../images/111815/111815-12/AASLD14.gif)
|
|
|
![](images/null.gif) |
![](images/null.gif) |
|
|